Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1999
03/11/1999CA2302248A1 Improved compositions and methods for the control of smoking
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900843A2 FfH polypeptide from Streptococcus
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900568A2 AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
03/10/1999EP0900567A2 Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
03/10/1999EP0900384A2 Novel treatment
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900235A1 Fragments of cr1 and their use
03/10/1999EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
03/10/1999EP0900219A1 Heterocyclic compounds
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900217A1 Heterocyclic compounds
03/10/1999EP0900212A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
03/10/1999EP0900204A1 Heterocyclic compounds
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900200A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/10/1999EP0900086A1 Enhancement of sleep with a growth hormone secretagogue
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900082A1 Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999EP0900078A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
03/10/1999EP0900076A1 Transdermal device
03/10/1999CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/10/1999CN1210534A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210532A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210530A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880132 Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception
03/09/1999US5880120 Treating depression by administering an antidepressant
03/09/1999US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879710 Comprising melatonin and melatonin derivatives, acrylic acid polymeric resin, magnesium stearate, lactose diluent, polyvinylpyrrolidinone and cellulose derivatives
03/09/1999US5879702 Analgesic anti-inflammatory adhesive preparations
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/09/1999CA2002761C Adhesive tape preparation of clonidine
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010378A1 Pompilid wasp-derived neuropeptides
03/04/1999WO1999010347A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
03/04/1999WO1999010346A1 Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
03/04/1999WO1999010344A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999WO1999010340A1 Compounds possessing neuronal activity
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
03/04/1999WO1999010330A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999009999A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999WO1999009981A1 Use of phanquinone for the treatment of alzheimer's disease
03/04/1999WO1999009980A1 Method for treating pain
03/04/1999WO1999009979A1 Method for treating neuropathic pain
03/04/1999WO1999009972A1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome
03/04/1999WO1999009837A1 Chemical and pharmacological standardization of herbal extracts
03/04/1999WO1998054183A3 Ergoline derivatives and their use as somatostatin receptor antagonists
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999CA2302504A1 Method for treating pain
03/04/1999CA2302442A1 Method for treating neuropathic pain
03/04/1999CA2301821A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301750A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2300134A1 Compounds possessing neuronal activity
03/04/1999CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899267A1 Disubstituted trans-3,4,4a,5,6,10b-hexahydro-2H-napht(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical compositions containing them
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898967A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
03/03/1999EP0898569A1 Piperidines and pyrrolidines
03/03/1999EP0898567A1 Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
03/03/1999EP0898566A1 Substituted benzylamines and their use for the treatment of depression
03/03/1999EP0898478A1 Stimulation of host defence mechanisms against tumors
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999EP0737194B1 Diazabicyclic neurokinin antagonists
03/03/1999EP0675893B1 Anticonvulsant sorbopyranose sulfamates
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999EP0605697B1 Indol derivatives for the treatment of migraine
03/03/1999CN1209807A 1-pyrazol-3-yl-ethyl-4-indol-3-yl piperdine as medicine acting on central nervous system
03/03/1999CN1209805A Noval fused pyrrolecarboxamides and new class of GABA brain receptor ligands
03/03/1999CN1209741A Preparations of non-steroidal analgesics
03/03/1999CN1042331C 4,6-dichloro-3-substituted-2-carboxy indole derivative
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877399 Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
03/02/1999US5877321 Neurokinin receptor
03/02/1999US5877317 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
03/02/1999US5877316 Treatment of pain, inflammation, migraine and emesis.
03/02/1999US5877199 Heterocyclic compounds, their preparation and their therapeutic use
03/02/1999US5877193 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
1 ... 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 ... 1833